TY  - GEN
AU  - Robinson,Stephen P
AU  - Goldstone,Anthony H
AU  - Mackinnon,Stephen
AU  - Carella,Angelo
AU  - Russell,Nigel
AU  - de Elvira,Carmen Ruiz
AU  - Taghipour,Goli
AU  - Schmitz,Norbert
TI  - Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation
SN  - 0006-4971
PY  - 2003///0128
KW  - Adult
KW  - Aged
KW  - Alemtuzumab
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Humanized
KW  - Antibodies, Neoplasm
KW  - Antilymphocyte Serum
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Bone Marrow Transplantation
KW  - Carmustine
KW  - Cohort Studies
KW  - Cytarabine
KW  - Disease Progression
KW  - Drug Resistance, Neoplasm
KW  - Europe
KW  - epidemiology
KW  - Female
KW  - Follow-Up Studies
KW  - Graft Survival
KW  - Graft vs Host Disease
KW  - Hodgkin Disease
KW  - drug therapy
KW  - Humans
KW  - Immunosuppressive Agents
KW  - therapeutic use
KW  - Life Tables
KW  - Lymphoma, Non-Hodgkin
KW  - Male
KW  - Melphalan
KW  - Middle Aged
KW  - Peripheral Blood Stem Cell Transplantation
KW  - adverse effects
KW  - Podophyllotoxin
KW  - Proportional Hazards Models
KW  - Salvage Therapy
KW  - Survival Analysis
KW  - Survival Rate
KW  - Transplantation Chimera
KW  - Transplantation Conditioning
KW  - Transplantation, Homologous
KW  - Treatment Outcome
KW  - Vidarabine
N1  - Publication Type: Comparative Study; Journal Article; Multicenter Study
UR  - https://doi.org/10.1182/blood-2001-11-0107
ER  -